Table 5.
50 mg ABX464 | 150 mg ABX464 | Placebo | Difference in proportion*
(95% CI) |
Fisher's exact test
P value |
||
---|---|---|---|---|---|---|
All evaluable participants at day 28 | n=2 | n=14 | n=4 | |||
Responder | 2 (100.0%) | 6 (42.9%) | 0 | |||
Non-responder | 0 | 8 (57.1%) | 4 (100.0%) | |||
42.9% (-10.6–67.4) | 0.2451 |
n: number of participants; CI: confidence interval.
*Difference in proportion is calculated for ABX464 150 mg versus placebo